BDX vs CMPX · P/E 34, rev $21.84B vs $367.4M cap
Becton Dickinson and Company (BDX) versus Compass Therapeutics Inc. (CMPX) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
CMPX does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CMPX currently screens at market cap $367.4M.
Not investment advice. Open the BDX and CMPX stock pages for the full models.
Not investment advice.